Hypnosis to Improve Well-beings of Critically Ill Patients and Prevent Post-intensive Care Syndrome
Post Intensive Care Syndrome (PICS)
What this study involves
The registry says this study is recruiting. Individual locations may have different availability.
- Study type
- Interventional
- Phase
- Not applicable
- Age range
- 18 years - Not specified
- Sex eligible
- All sexes
- Healthy volunteers
- Not accepted
- Participants
- 150 Estimated
These are starting points, not an eligibility decision. The research team must review the full requirements.
About the research
The goal of this clinical trial is to evaluate the effectiveness of a hypnosis intervention in improving well-being at day 28 of an ICU stay. The main question it aims to answer is :
-Does Hypnosis intervention at ICU discharge and on day 7 and 14 on the wards if the patient remains in the hospital, improve wellbeing at 28 days ?
Researchers will compare discharged ICU patients who received standard post-discharge care to discharged ICU patients who received standard post-discharge care and hypnosis intervention on discharge and 7 and 14days after if they are still in the hospital, to see if hypnosis can improve their wellbeing.
Participants will receive a hypnosis session on the day of ICU discharge, a second session seven days post-discharge and a third session at day 14 if they are still in the hospital.
Read the full description
Critically ill patients in the Intensive Care Unit (ICU) face numerous challenges both acutely and in the long term. These patients frequently experience acute pain and anxiety due to intubation and induced comas. Following their ICU discharge, they commonly report decreased well-being and quality of life. Additionally, up to 40% of critically ill patients develop post-intensive care syndrome (PICS), which includes mental, physical, and cognitive sequelae that can persist up to one year after discharge. Heavy sedation and medications necessary to manage pain and anxiety are known risk factors for PICS.
The current standard of care in the ICU includes mobilization and nutrition, pain control, and family engagement and empowerment. Furthermore, no other specific interventions are aimed at improving long-term outcomes and preventing PICS.
Several studies have explored using hypnosis to improve the acute care of ICU patients. For instance, a pain protocol that included hypnosis in burn patients hospitalized in the CHUV (Centre Hospitalier Universitaire Vaudois) resulted in reduced pain intensity, reduced opioid use, reduced anxiety, and better wound outcomes, all while lowering costs. A pilot study involving non-invasive ventilation patients showed that hypnosis could improve comfort, mask tolerance, and anxiety levels. Additionally, studies on relaxation therapy have indicated that electronic relaxation therapy is a promising, safe, and effective non-pharmacological solution to enhance overall comfort in alert and non-delirious ICU patients.
However, despite these efforts, there is a lack of efficient interventions specifically targeting the wellbeing of patients after an ICU stay and the prevention of PICS. Existing interventions, such as follow-up programs, rehabilitation, and psychological follow-up, have shown conflicting results. To date, no studies have specifically assessed the effect of hypnosis on the short and longer-term well-being of critically ill patients leaving the ICU and its possible effect on the prevention of PICS.
The investigators hypothesize that providing a hypnosis session at ICU discharge and followed by subsequent sessions on days 7 and 14 on the ward will improve well-being in the short term and reduce PICS symptoms at 3-months. The primary outcome will be the assessment of well-being at day 28 post-ICU discharge. Secondary outcomes will be anxiety, depression, PTSD, and quality of life at three months.
Hypothesis and primary objective The investigators hypothesize that providing intervention with hypnosis at ICU discharge and subsequent sessions on day 7 and 14 on the ward if the patient remains in the hospital will improve wellbeing at day 28 and reduce PICS symptoms at three months in critically ill patients.
Primary Objective:
The primary objective of this study is to evaluate the effectiveness of a hypnosis intervention in improving well-being at day 28 of an ICU stay.
Scale used for wellbeing:
- ESAS, total 90, each item on a 0-10 scale
- EQ-5D-5L
Secondary Objectives:
1. To assess the impact of a hypnosis intervention to improve PICS at 3 months
* Anxiety and depression: PHQ-9 et GAD-7
* Post-traumatic stress disorder: PDI and IES-R scale
* Quality of life: SF-12, EQ-5D-5L and WHODAS 2.0
* Patient impression of change: PGIC
2. To evaluate patient immediate wellbeing after the hypnosis intervention. • ESAS before after the session in patients who will get the session
Who may be able to participate?
The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.
Inclusion Criteria:
- On Mechanical Ventilation for at least 2 days
- Able to give informed consent as documented by signature
- French speaking
Exclusion Criteria:
- Refusal of the patient
- Patient transferred from another ICU
- Patient is planned for a withdrawal of care or is actively dying
- Glasgow coma scale (GCS) \<15 on ICU discharge
- Patient presenting with delirium (detected by CAM-ICU) on ICU discharge
- Patient hospitalized for traumatic brain injury
- Patient is in jail
- Patient hospitalized for more than 28 days in the ICU
Treatment, groups and participation
The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.
- Assignment
- Random assignment
- Masking
- Single masked
Hypnosis group
Participants in the intervention group will receive a hypnosis session on the day of discharge, a second session seven days post-discharge, and a third session on day 14 if they are still in the hospital. Trained professionals will conduct the hypnosis sessions following a standardized protocol, designed by the study team for critically ill patients.
Other: Hypnosis
Control group
Participants in the control group will receive standard post-discharge care, which includes mobilization, nutrition, pain control, and family engagement and empowerment, without any hypnosis intervention.
Hypnosis OTHER
the hypnosis will be tailored to each patient. Key elements will include relaxation (to mitigate anxiety and stress and help the patient feel more comfortable, secure, and competent), reassociation techniques (to help the patient reconnect with their body, promoting a sense of embodiment and presence), and safe place (to introduce a safe and calming place to instill a sense of control and competence, aiding in emotional stabilization and fostering a sense of safety and well-being).
What researchers are measuring
Outcome measures describe what is being studied. They are not proof that a treatment works.
Primary measures
Wellbeing at day 28 post intensive care unit discharge
Time frame: Day 28 post intensive care unit discharge
ESAS scale (Edmonton Symptom Assessment System) with a range from 0 to 100. Higher scores means worse wellbeing.
Secondary measures
Immediate wellbeing following a hypnosis session
Time frame: Day 1 (Day of discharge from ICU), day 7, day 14
1\) ESAS scale before and after the hypnosis session performed on Day 1 (ICU discharge), Day 7 and D14
-The ESAS scale (Edmonton Symptom Assessment System) has a range from 0 to 100.
PDI - Peritraumatic distress inventory
Time frame: day 28 post ICU discharge
PDI (Peritraumatic distress index, range: 13-65)
PHQ-9 - Patient Health Questionnaire-9
Time frame: Day 28 post intensive care unit discharge and 3 months post intensive care
PHQ-9 (Patient Health Questionnaire-9: range 0-27) will be used to assess depressive symptoms at day 28 and 3 months
GAD-7 - Generalized Anxiety Disorder-7
Time frame: at day 28 and 3 months post ICU discharge
GAD-7 (Generalized Anxiety Disorder-7, range 0-21) will be used to assess anxiety symptoms at day 28 and 3 months post ICU discharge
IES-R (Impact of event Scale)
Time frame: 3 months post intensive care unit discharge. Higher score means more PTSD symptoms.
Range: 0-88
EQ-5D-5L (Quality of life)
Time frame: Day 28 post intensive care unit discharge and 3 months post intensive care unit discharge
Part 1) 5 dimensions: Mobility, Self-care, Usual activities, Pain/discomfort, Anxiety/depression. The 5-digit health state is converted (via country-specific value set) to an index value
Part 2) EQ VAS (Visual Analog Scale). Patient rates their health today from 0 to 100.
Higher scores mean better quality of life.
PGIC - Patient Global Impression of Change
Time frame: Day 28 post intensive care unit discharge and 3 months post intensive care unit discharge
Single-item global rating of how much the patient feels their condition has changed since a reference time. Higher scores means improvement.
Scoring / range: 1-7
Review the complete result tables and limitations in the official record.
Open official results ↗Research locations (2)
The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.
2 locations
University Hospital of GenevaGeneva, SwitzerlandRecruiting
Hôpitaux NeuchâteloisNeuchâtel, SwitzerlandNot yet recruiting
Study team and timeline
- Lead sponsor
- COEN Matteo
- Study start
- Mar 16, 2026 Actual
- Primary completion
- Oct 1, 2027 Estimated
- Study completion
- Dec 1, 2027 Estimated
- First posted
- Nov 28, 2025 Actual
- Last updated
- Nov 10, 2026 Actual
Official study contacts
Official study title
Hypnosis to Improve Well-beings of Critically Ill Patients and Prevent Post-intensive Care Syndrome
Ask Wellness Clinical Research
Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.
Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.
Retrieved: Nov 12, 2026 · Last registry update: Nov 10, 2026
